Physician
Pediatric and Adult Prompt Care LLC
Pediatric and Adult Prompt Care LLC was paid $6.91M by Medicaid between Jan 2018 and Dec 2024, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 75% of everything it billed.
33Billing provider infoPEDIATRIC AND ADULT PROMPT CARE LLC
LOUISVILLE, KY 40202
LOUISVILLE, KY 40202
33aNPI1760713796assigned 01/14/2010
33bProvider typeInternal Medicine Physician
28Total paid$6.91M
24GClaims98,143
24DCodes billed7
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Kentucky
Rank by total paid#4 of 231
Median peer was paid$77K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,248 | $840K | |
| 2019 | 9,964 | $724K | |
| 2020 | 8,036 | $566K | |
| 2021 | 12,411 | $850K | |
| 2022 | 19,013 | $1.36M | |
| 2023 | 18,894 | $1.35M | |
| 2024incomplete | 17,577 | $1.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 75% | 73,771 | 62,069 | $5.18M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 23% | 21,995 | 19,678 | $1.58M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 1,179 | 1,109 | $84K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 733 | 693 | $52K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 161 | 111 | $10K |
| 86328 | <1% | 284 | 256 | $9K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 20 | 20 | $35.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAQ, AKASHA (CEO)